Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"AMG 424 multiple myeloma" - Google News
Get the latest updates from "AMG 424 multiple myeloma" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells - Nature.com
about 2 years ago
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth...
Advancing T-Cell Redirecting Agents in Prostate Cancer - Targeted Oncology
over 2 years ago
Advancing T-Cell Redirecting Agents in Prostate Cancer Targeted Oncology
Harpoon Therapeutics: A First Look - Seeking Alpha
over 2 years ago
Harpoon Therapeutics: A First Look Seeking Alpha
Harpoon Therapeutics: A First Look - Seeking Alpha
over 2 years ago
Harpoon Therapeutics: A First Look Seeking Alpha
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma - News-Medical.net
over 2 years ago
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma News-Medical.net
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma - News-Medical.net
over 2 years ago
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma News-Medical.net
Form S-3 Sorrento Therapeutics, - StreetInsider.com
almost 3 years ago
Form S-3 Sorrento Therapeutics, StreetInsider.com
Form S-3 Sorrento Therapeutics, - StreetInsider.com
almost 3 years ago
Form S-3 Sorrento Therapeutics, StreetInsider.com
Romiplostim mechanism of action and clinical applicability | DDDT - Dove Medical Press
almost 3 years ago
Romiplostim mechanism of action and clinical applicability | DDDT Dove Medical Press
Global Anti-Cd38 Antibody Pipeline Insight Report 2021 Featuring Emerging Drugs Such as Felzartamab (MOR202): MorphoSys & STI-6129: Sorrento Therapeutics - ResearchAndMarkets.com - Business Wire
almost 3 years ago
Global Anti-Cd38 Antibody Pipeline Insight Report 2021 Featuring Emerging Drugs Such as...
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
almost 3 years ago
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings...
Sorrento Therapeutics, Inc. S-3 Apr. 9, 2021 5:05 PM - Seeking Alpha
about 3 years ago
Sorrento Therapeutics, Inc. S-3 Apr. 9, 2021 5:05 PM Seeking Alpha